QUCY vs RAPP

Quantum Cyber N.V. vs Rapport Therapeutics, Inc. — Valuation Comparison 2026

QUCY

Pharmaceutical Preparations
Quantum Cyber N.V.
Quality
1.9
out of 10
Value Trap
Price
$2.56
Last close
Models
10/13
Active
VS

RAPP

Pharmaceutical Preparations
Rapport Therapeutics, Inc.
Quality
4.2
out of 10
Value Trap
12
SAFE
Price
$39.50
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType QUCY Fair ValueQUCY Upside RAPP Fair ValueRAPP Upside
Bayesian DCF Intrinsic $1.07 -58.3% $10.45 -73.6%
Earnings Power Value Intrinsic $0.72 +75.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.10 -96.1% $3.95 -90.0%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for QUCY vs RAPP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

QUCY vs RAPP — Which Stock Is More Undervalued?

RAPP scores higher with a 4.2/10 quality rating vs QUCY's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Quantum Cyber N.V. (QUCY) and Rapport Therapeutics, Inc. (RAPP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

QUCY currently trades at $2.56 with a QOC of 1.9/10, while RAPP trades at $39.50 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).